Regeneron Pharmaceuticals Inc

FDA Regulatory Profile

Summary

Total Recalls
2
510(k) Clearances
0
Inspections
22
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0531-2024Class IIEYLEA, (aflibercept) Injection, For Intravitreal injection, 2 mg (0.05mL of a 40mg/mL solution), SinMay 15, 2024
D-0479-2024Class IIEYLEA, (aflibercept) Injection, 2 mg (0.05mL of a 40mg/mL solution), Single-dose Pre-filled Syringe,April 23, 2024